Dr. Mullins says that methods for evaluating comparative- and cost-effectiveness of treatment are evolving. He points out that side effects may represent significant burdens to patients and need to be considered to understand the true value of using improved therapies that reduce side effects.
Hear Dr. Joseph Antos speak on healthcare spending. This interview was conducted on February 28, 2014.

Results 1 - 2 of 2
  •  Association for Value-Based Cancer Care
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Oncology Practice Management
  • Rheumatology Practice Management
  • Urology Practice Management
  • Inside Patient Care: Pharmacy & Clinic
  • Lynx CME